QQ客服 官方微博 反馈留言

	Effectiveness and the strategy to treat the side effects of sorafenib administration after transarterial chemoembolization in advanced hepatocellular carcinoma patients
	Zhang, Kai; Sun, Xiangyang; Xie, Fubo; Jian, Wencheng; Li, Caixia
刊名	JOURNAL OF CANCER RESEARCH AND THERAPEUTICS
	2018
卷号	14期号:1页码:196-200
关键词	Hepatocellular carcinoma molecular targeted therapy sorafenib transarterial chemoembolization
DOI	10.4103/jcrt.JCRT_1175_16
URL标识	查看原文
公开日期	[db:dc_date_available]
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/4564850
专题	山东大学
作者单位	Shandong Univ, Qilu Hosp, Dept Radiol, Jinan, Shandong, Peoples R China.
推荐引用方式 GB/T 7714	Zhang, Kai,Sun, Xiangyang,Xie, Fubo,et al. Effectiveness and the strategy to treat the side effects of sorafenib administration after transarterial chemoembolization in advanced hepatocellular carcinoma patients[J]. JOURNAL OF CANCER RESEARCH AND THERAPEUTICS,2018,14(1):196-200.
APA	Zhang, Kai,Sun, Xiangyang,Xie, Fubo,Jian, Wencheng,&Li, Caixia.(2018).Effectiveness and the strategy to treat the side effects of sorafenib administration after transarterial chemoembolization in advanced hepatocellular carcinoma patients.JOURNAL OF CANCER RESEARCH AND THERAPEUTICS,14(1),196-200.
MLA	Zhang, Kai,et al."Effectiveness and the strategy to treat the side effects of sorafenib administration after transarterial chemoembolization in advanced hepatocellular carcinoma patients".JOURNAL OF CANCER RESEARCH AND THERAPEUTICS 14.1(2018):196-200.

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。